CD8A and infection: A subpopulation of these cells has recently been classified as tissue resident effector memory (Trm) cells that produce higher amounts of IFNγ than CD3+CD8+CD103- cells, accumulate locally following intracellular infections at mucosal sites [59, 60] and thus represent an emerging target for mucosal vaccine development [61, 62].